Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Overexpression of vascular endothelial growth factor in the germinal matrix induces neurovascular proteases and intraventricular hemorrhage.

Yang D, Baumann JM, Sun YY, Tang M, Dunn RS, Akeson AL, Kernie SG, Kallapur S, Lindquist DM, Huang EJ, Potter SS, Liang HC, Kuan CY.

Sci Transl Med. 2013 Jul 10;5(193):193ra90. doi: 10.1126/scitranslmed.3005794.

2.

Lymphatic ontogeny and effect of hypoplasia in developing lung.

Kulkarni RM, Herman A, Ikegami M, Greenberg JM, Akeson AL.

Mech Dev. 2011 Jan-Feb;128(1-2):29-40. doi: 10.1016/j.mod.2010.09.003. Epub 2010 Oct 12.

3.

Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease.

Hakroush S, Moeller MJ, Theilig F, Kaissling B, Sijmonsma TP, Jugold M, Akeson AL, Traykova-Brauch M, Hosser H, Hähnel B, Gröne HJ, Koesters R, Kriz W.

Am J Pathol. 2009 Nov;175(5):1883-95. doi: 10.2353/ajpath.2009.080792. Epub 2009 Oct 15.

4.

NFATc1 regulates lymphatic endothelial development.

Kulkarni RM, Greenberg JM, Akeson AL.

Mech Dev. 2009 May-Jun;126(5-6):350-65. doi: 10.1016/j.mod.2009.02.003. Epub 2009 Feb 20.

5.

Lymphangiogenesis in the developing lung promoted by VEGF-A.

Mallory BP, Mead TJ, Wiginton DA, Kulkarni RM, Greenberg JM, Akeson AL.

Microvasc Res. 2006 Jul-Sep;72(1-2):62-73. Epub 2006 Jun 23.

PMID:
16806288
6.

Vascular endothelial growth factor-A induces prenatal neovascularization and alters bronchial development in mice.

Akeson AL, Cameron JE, Le Cras TD, Whitsett JA, Greenberg JM.

Pediatr Res. 2005 Jan;57(1):82-8. Epub 2004 Nov 19.

PMID:
15557114
7.

Slit and robo expression in the developing mouse lung.

Greenberg JM, Thompson FY, Brooks SK, Shannon JM, Akeson AL.

Dev Dyn. 2004 Jun;230(2):350-60.

8.

VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice.

Le Cras TD, Spitzmiller RE, Albertine KH, Greenberg JM, Whitsett JA, Akeson AL.

Am J Physiol Lung Cell Mol Physiol. 2004 Jul;287(1):L134-42. Epub 2004 Mar 19.

9.

Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung.

Akeson AL, Greenberg JM, Cameron JE, Thompson FY, Brooks SK, Wiginton D, Whitsett JA.

Dev Biol. 2003 Dec 15;264(2):443-55.

10.

Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung.

Greenberg JM, Thompson FY, Brooks SK, Shannon JM, McCormick-Shannon K, Cameron JE, Mallory BP, Akeson AL.

Dev Dyn. 2002 Jun;224(2):144-53.

11.
12.

Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme.

Akeson AL, Wetzel B, Thompson FY, Brooks SK, Paradis H, Gendron RL, Greenberg JM.

Dev Dyn. 2000 Jan;217(1):11-23.

13.

AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1.

Akeson AL, Woods CW, Hsieh LC, Bohnke RA, Ackermann BL, Chan KY, Robinson JL, Yanofsky SD, Jacobs JW, Barrett RW, Bowlin TL.

J Biol Chem. 1996 Nov 29;271(48):30517-23.

14.

Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes.

Ikeda M, Schroeder KK, Mosher LB, Woods CW, Akeson AL.

J Invest Dermatol. 1994 Dec;103(6):791-6.

15.

A fluorometric assay for the quantitation of cell adherence to endothelial cells.

Akeson AL, Woods CW.

J Immunol Methods. 1993 Aug 9;163(2):181-5.

PMID:
8354887
16.

Identification of a specific receptor for interleukin-1 in vascular smooth muscle cells: regulation by interleukin-1 and interleukin-6.

French JF, Schroeder KK, Akeson AL, Dage RC, Bowlin TL.

Eur J Pharmacol. 1993 Mar 16;233(1):109-12.

PMID:
8472739
17.

Human aortic endothelial cells express the type I but not the type II receptor for interleukin-1 (IL-1).

Akeson AL, Mosher LB, Woods CW, Schroeder KK, Bowlin TL.

J Cell Physiol. 1992 Dec;153(3):583-8.

PMID:
1360015
18.
19.

Suppression of interleukin-1 beta and LDL scavenger receptor expression in macrophages by a selective protein kinase C inhibitor.

Akeson AL, Schroeder K, Woods C, Schmidt CJ, Jones WD.

J Lipid Res. 1991 Oct;32(10):1699-707.

20.

Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol.

Akeson AL, Woods CW, Mosher LB, Thomas CE, Jackson RL.

Atherosclerosis. 1991 Feb;86(2-3):261-70.

PMID:
1872919
21.

Products of oxidized linoleate mediate the release of interleukin-1 beta from human macrophages.

Ku G, Akeson AL, Mano M, Thomas CE, Jackson RL.

Trans Assoc Am Physicians. 1991;104:107-12. No abstract available.

PMID:
1845137
22.

Accessory cells induce a polyphosphatidylinositol response when cultured with mitogen-activated T lymphocytes.

Akeson AL, Mitani K, McCarthy BM, Harmony JA.

J Cell Physiol. 1990 Nov;145(2):356-64.

PMID:
2246334
23.

Normal and mutant human adenosine deaminase genes.

Akeson AL, Wiginton DA, Hutton JJ.

J Cell Biochem. 1989 Mar;39(3):217-28. Review.

PMID:
2651461
24.

Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.

Akeson AL, Wiginton DA, Dusing MR, States JC, Hutton JJ.

J Biol Chem. 1988 Nov 5;263(31):16291-6.

25.

Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.

Akeson AL, Wiginton DA, States JC, Perme CM, Dusing MR, Hutton JJ.

Proc Natl Acad Sci U S A. 1987 Aug;84(16):5947-51.

26.
27.

Complete sequence and structure of the gene for human adenosine deaminase.

Wiginton DA, Kaplan DJ, States JC, Akeson AL, Perme CM, Bilyk IJ, Vaughn AJ, Lattier DL, Hutton JJ.

Biochemistry. 1986 Dec 16;25(25):8234-44.

PMID:
3028473
29.

Brain pyruvate kinase activity in PKU model systems.

Akeson AL, Berry HK, Brunner RL, Vorhees CV.

J Neurochem. 1979 Jan;32(1):233-5. No abstract available.

PMID:
153382

Supplemental Content

Loading ...
Support Center